BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18956949)

  • 1. Effects of generation time on spray aerosol transport and deposition in models of the mouth-throat geometry.
    Worth Longest P; Hindle M; Das Choudhuri S
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):67-83. PubMed ID: 18956949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.
    Worth Longest P; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):99-112. PubMed ID: 18956950
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Wei X; Hindle M; Kaviratna A; Huynh BK; Delvadia RR; Sandell D; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):358-371. PubMed ID: 29878859
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.
    Hindle M; Longest PW
    Pharm Res; 2010 Sep; 27(9):1800-11. PubMed ID: 20454837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis and design of a spray aerosol inhaler. Part 1: effects of dilution air inlets and flow paths.
    Longest PW; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2009 Sep; 22(3):271-83. PubMed ID: 19466904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.
    Delvadia RR; Longest PW; Hindle M; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):145-56. PubMed ID: 23025452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis and design of a spray aerosol inhaler. Part 2: improvements in mouthpiece performance.
    Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):237-47. PubMed ID: 23098326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of Particles in Human Mouth-Throat Replicas and a USP Induction Port.
    Cheng YS; Zhou Y; Su WC
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):147-55. PubMed ID: 25137223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo-in vitro comparison of deposition in three mouth-throat models with Qvar and Turbuhaler inhalers.
    Zhang Y; Gilbertson K; Finlay WH
    J Aerosol Med; 2007; 20(3):227-35. PubMed ID: 17894531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model.
    Kim J; Xi J; Si X; Berlinski A; Su WC
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):209-18. PubMed ID: 23808762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Fluid Dynamics (CFD) Guided Spray Drying Recommendations for Improved Aerosol Performance of a Small-Particle Antibiotic Formulation.
    Longest W; Hassan A; Farkas D; Hindle M
    Pharm Res; 2022 Feb; 39(2):295-316. PubMed ID: 35147870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the lung delivery of nasally administered aerosols during noninvasive ventilation-an application of enhanced condensational growth (ECG).
    Longest PW; Tian G; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):103-18. PubMed ID: 21410327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro monodisperse aerosol deposition in a mouth and throat with six different inhalation devices.
    DeHaan WH; Finlay WH
    J Aerosol Med; 2001; 14(3):361-7. PubMed ID: 11693848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data.
    Tian G; Hindle M; Lee S; Longest PW
    Pharm Res; 2015 Oct; 32(10):3170-87. PubMed ID: 25944585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Bio-relevant Mouth-Throat Models for Characterization of Metered Dose Inhalers.
    Kaviratna A; Tian G; Liu X; Delvadia R; Lee S; Guo C
    AAPS PharmSciTech; 2019 Feb; 20(3):130. PubMed ID: 30815748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple mechanistic model of deposition of water-soluble aerosol particles in the mouth and throat.
    Mitsakou C; Mitrakos D; Neofytou P; Housiadas C
    J Aerosol Med; 2007; 20(4):519-29. PubMed ID: 18158723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and deposition of micro-aerosols in realistic and simplified models of the oral airway.
    Xi J; Longest PW
    Ann Biomed Eng; 2007 Apr; 35(4):560-81. PubMed ID: 17237991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.
    Longest PW; Tian G; Walenga RL; Hindle M
    Pharm Res; 2012 Jun; 29(6):1670-88. PubMed ID: 22290350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dry powder inhaler aerosol deposition in a model of tracheobronchial airways: Validating CFD predictions with in vitro data.
    Ahookhosh K; Saidi M; Aminfar H; Mohammadpourfard M; Hamishehkar H; Yaqoubi S
    Int J Pharm; 2020 Sep; 587():119599. PubMed ID: 32663586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.